The global Substance Abuse Therapeutics market is projected to grow from US$ 19130 million in 2024 to US$ 27740 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.4% during the forecast period.

Substance Abuse Therapeutics Market

Substance Abuse can be defined as habitually, dependence of an individual on any drugs, which turns into an addiction. Opioid, alcohol, tobacco and cigarettes are some of the common, drugs which has been misused leading to drugs addictions. In recent past, many products have been launched in market for treatment and management of substance abuse. Some commonly used drug for treatment of substance abuse are Disulfiram, Acamprosate, Naltrexone, Nicotine Replacement Treatment, Methadone, and Buprenorphine.

Market Analysis and Insights: Global Substance Abuse Therapeutics Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Substance Abuse Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Substance Abuse Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Substance Abuse Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Substance Abuse Therapeutics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Substance Abuse Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Substance Abuse Therapeutics revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Substance Abuse Therapeutics Market Report

Report Metric	Details
Report Name	Substance Abuse Therapeutics Market
Accounted market size in 2024	US$ 19130 in million
Forecasted market size in 2030	US$ 27740 million
CAGR	6.4
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Opioid Addiction Tobacco/Nicotine Addiction Alcohol Dependence
Segment by Application	Hospital & Clinics Residential (non-hospital)
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Indivior, Pfizer, Alkermes, Novartis, Mylan, Cipla, Glenmark, Dr. Reddy's Laboratories, Teva Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Substance Abuse Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Substance Abuse Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Substance Abuse Therapeutics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Substance Abuse Therapeutics Market growing?

Ans: The Substance Abuse Therapeutics Market witnessing a CAGR of 6.4 during the forecast period 2025-2030.

What is the Substance Abuse Therapeutics Market size in 2030?

Ans: The Substance Abuse Therapeutics Market size in 2030 will be US$ 27740 million.

Who are the main players in the Substance Abuse Therapeutics Market report?

Ans: The main players in the Substance Abuse Therapeutics Market are Indivior, Pfizer, Alkermes, Novartis, Mylan, Cipla, Glenmark, Dr. Reddy's Laboratories, Teva Pharmaceutical

What are the Application segmentation covered in the Substance Abuse Therapeutics Market report?

Ans: The Applications covered in the Substance Abuse Therapeutics Market report are Hospital & Clinics, Residential (non-hospital)

What are the Type segmentation covered in the Substance Abuse Therapeutics Market report?

Ans: The Types covered in the Substance Abuse Therapeutics Market report are Opioid Addiction, Tobacco/Nicotine Addiction, Alcohol Dependence

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Substance Abuse Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Opioid Addiction

1.2.3 Tobacco/Nicotine Addiction

1.2.4 Alcohol Dependence

1.3 Market by Application

1.3.1 Global Substance Abuse Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospital & Clinics

1.3.3 Residential (non-hospital)

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Substance Abuse Therapeutics Market Perspective (2019-2030)

2.2 Global Substance Abuse Therapeutics Growth Trends by Region

2.2.1 Substance Abuse Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Substance Abuse Therapeutics Historic Market Size by Region (2019-2024)

2.2.3 Substance Abuse Therapeutics Forecasted Market Size by Region (2025-2030)

2.3 Substance Abuse Therapeutics Market Dynamics

2.3.1 Substance Abuse Therapeutics Industry Trends

2.3.2 Substance Abuse Therapeutics Market Drivers

2.3.3 Substance Abuse Therapeutics Market Challenges

2.3.4 Substance Abuse Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Substance Abuse Therapeutics by Players

3.1.1 Global Substance Abuse Therapeutics Revenue by Players (2019-2024)

3.1.2 Global Substance Abuse Therapeutics Revenue Market Share by Players (2019-2024)

3.2 Global Substance Abuse Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Substance Abuse Therapeutics, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Substance Abuse Therapeutics Market Concentration Ratio

3.4.1 Global Substance Abuse Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Substance Abuse Therapeutics Revenue in 2023

3.5 Global Key Players of Substance Abuse Therapeutics Head office and Area Served

3.6 Global Key Players of Substance Abuse Therapeutics, Product and Application

3.7 Global Key Players of Substance Abuse Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Substance Abuse Therapeutics Breakdown Data by Type

4.1 Global Substance Abuse Therapeutics Historic Market Size by Type (2019-2024)

4.2 Global Substance Abuse Therapeutics Forecasted Market Size by Type (2025-2030)

5 Substance Abuse Therapeutics Breakdown Data by Application

5.1 Global Substance Abuse Therapeutics Historic Market Size by Application (2019-2024)

5.2 Global Substance Abuse Therapeutics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Substance Abuse Therapeutics Market Size (2019-2030)

6.2 North America Substance Abuse Therapeutics Market Size by Type

6.2.1 North America Substance Abuse Therapeutics Market Size by Type (2019-2024)

6.2.2 North America Substance Abuse Therapeutics Market Size by Type (2025-2030)

6.2.3 North America Substance Abuse Therapeutics Market Share by Type (2019-2030)

6.3 North America Substance Abuse Therapeutics Market Size by Application

6.3.1 North America Substance Abuse Therapeutics Market Size by Application (2019-2024)

6.3.2 North America Substance Abuse Therapeutics Market Size by Application (2025-2030)

6.3.3 North America Substance Abuse Therapeutics Market Share by Application (2019-2030)

6.4 North America Substance Abuse Therapeutics Market Size by Country

6.4.1 North America Substance Abuse Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Substance Abuse Therapeutics Market Size by Country (2019-2024)

6.4.3 North America Substance Abuse Therapeutics Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Substance Abuse Therapeutics Market Size (2019-2030)

7.2 Europe Substance Abuse Therapeutics Market Size by Type

7.2.1 Europe Substance Abuse Therapeutics Market Size by Type (2019-2024)

7.2.2 Europe Substance Abuse Therapeutics Market Size by Type (2025-2030)

7.2.3 Europe Substance Abuse Therapeutics Market Share by Type (2019-2030)

7.3 Europe Substance Abuse Therapeutics Market Size by Application

7.3.1 Europe Substance Abuse Therapeutics Market Size by Application (2019-2024)

7.3.2 Europe Substance Abuse Therapeutics Market Size by Application (2025-2030)

7.3.3 Europe Substance Abuse Therapeutics Market Share by Application (2019-2030)

7.4 Europe Substance Abuse Therapeutics Market Size by Country

7.4.1 Europe Substance Abuse Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Substance Abuse Therapeutics Market Size by Country (2019-2024)

7.4.3 Europe Substance Abuse Therapeutics Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Substance Abuse Therapeutics Market Size (2019-2030)

8.2 China Substance Abuse Therapeutics Market Size by Type

8.2.1 China Substance Abuse Therapeutics Market Size by Type (2019-2024)

8.2.2 China Substance Abuse Therapeutics Market Size by Type (2025-2030)

8.2.3 China Substance Abuse Therapeutics Market Share by Type (2019-2030)

8.3 China Substance Abuse Therapeutics Market Size by Application

8.3.1 China Substance Abuse Therapeutics Market Size by Application (2019-2024)

8.3.2 China Substance Abuse Therapeutics Market Size by Application (2025-2030)

8.3.3 China Substance Abuse Therapeutics Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Substance Abuse Therapeutics Market Size (2019-2030)

9.2 Asia Substance Abuse Therapeutics Market Size by Type

9.2.1 Asia Substance Abuse Therapeutics Market Size by Type (2019-2024)

9.2.2 Asia Substance Abuse Therapeutics Market Size by Type (2025-2030)

9.2.3 Asia Substance Abuse Therapeutics Market Share by Type (2019-2030)

9.3 Asia Substance Abuse Therapeutics Market Size by Application

9.3.1 Asia Substance Abuse Therapeutics Market Size by Application (2019-2024)

9.3.2 Asia Substance Abuse Therapeutics Market Size by Application (2025-2030)

9.3.3 Asia Substance Abuse Therapeutics Market Share by Application (2019-2030)

9.4 Asia Substance Abuse Therapeutics Market Size by Region

9.4.1 Asia Substance Abuse Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Substance Abuse Therapeutics Market Size by Region (2019-2024)

9.4.3 Asia Substance Abuse Therapeutics Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Substance Abuse Therapeutics Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Substance Abuse Therapeutics Market Size by Type

10.2.1 Middle East, Africa, and Latin America Substance Abuse Therapeutics Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Substance Abuse Therapeutics Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Substance Abuse Therapeutics Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Substance Abuse Therapeutics Market Size by Application

10.3.1 Middle East, Africa, and Latin America Substance Abuse Therapeutics Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Substance Abuse Therapeutics Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Substance Abuse Therapeutics Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Substance Abuse Therapeutics Market Size by Country

10.4.1 Middle East, Africa, and Latin America Substance Abuse Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Substance Abuse Therapeutics Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Substance Abuse Therapeutics Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Indivior

11.1.1 Indivior Company Details

11.1.2 Indivior Business Overview

11.1.3 Indivior Substance Abuse Therapeutics Introduction

11.1.4 Indivior Revenue in Substance Abuse Therapeutics Business (2019-2024)

11.1.5 Indivior Recent Developments

11.2 Pfizer

11.2.1 Pfizer Company Details

11.2.2 Pfizer Business Overview

11.2.3 Pfizer Substance Abuse Therapeutics Introduction

11.2.4 Pfizer Revenue in Substance Abuse Therapeutics Business (2019-2024)

11.2.5 Pfizer Recent Developments

11.3 Alkermes

11.3.1 Alkermes Company Details

11.3.2 Alkermes Business Overview

11.3.3 Alkermes Substance Abuse Therapeutics Introduction

11.3.4 Alkermes Revenue in Substance Abuse Therapeutics Business (2019-2024)

11.3.5 Alkermes Recent Developments

11.4 Novartis

11.4.1 Novartis Company Details

11.4.2 Novartis Business Overview

11.4.3 Novartis Substance Abuse Therapeutics Introduction

11.4.4 Novartis Revenue in Substance Abuse Therapeutics Business (2019-2024)

11.4.5 Novartis Recent Developments

11.5 Mylan

11.5.1 Mylan Company Details

11.5.2 Mylan Business Overview

11.5.3 Mylan Substance Abuse Therapeutics Introduction

11.5.4 Mylan Revenue in Substance Abuse Therapeutics Business (2019-2024)

11.5.5 Mylan Recent Developments

11.6 Cipla

11.6.1 Cipla Company Details

11.6.2 Cipla Business Overview

11.6.3 Cipla Substance Abuse Therapeutics Introduction

11.6.4 Cipla Revenue in Substance Abuse Therapeutics Business (2019-2024)

11.6.5 Cipla Recent Developments

11.7 Glenmark

11.7.1 Glenmark Company Details

11.7.2 Glenmark Business Overview

11.7.3 Glenmark Substance Abuse Therapeutics Introduction

11.7.4 Glenmark Revenue in Substance Abuse Therapeutics Business (2019-2024)

11.7.5 Glenmark Recent Developments

11.8 Dr. Reddy's Laboratories

11.8.1 Dr. Reddy's Laboratories Company Details

11.8.2 Dr. Reddy's Laboratories Business Overview

11.8.3 Dr. Reddy's Laboratories Substance Abuse Therapeutics Introduction

11.8.4 Dr. Reddy's Laboratories Revenue in Substance Abuse Therapeutics Business (2019-2024)

11.8.5 Dr. Reddy's Laboratories Recent Developments

11.9 Teva Pharmaceutical

11.9.1 Teva Pharmaceutical Company Details

11.9.2 Teva Pharmaceutical Business Overview

11.9.3 Teva Pharmaceutical Substance Abuse Therapeutics Introduction

11.9.4 Teva Pharmaceutical Revenue in Substance Abuse Therapeutics Business (2019-2024)

11.9.5 Teva Pharmaceutical Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Dr. Reddy’s Laboratories

Teva Pharmaceutical

List of Tables

Table 1. Global Substance Abuse Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Opioid Addiction

Table 3. Key Players of Tobacco/Nicotine Addiction

Table 4. Key Players of Alcohol Dependence

Table 5. Global Substance Abuse Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 6. Global Substance Abuse Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Substance Abuse Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Substance Abuse Therapeutics Market Share by Region (2019-2024)

Table 9. Global Substance Abuse Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Substance Abuse Therapeutics Market Share by Region (2025-2030)

Table 11. Substance Abuse Therapeutics Market Trends

Table 12. Substance Abuse Therapeutics Market Drivers

Table 13. Substance Abuse Therapeutics Market Challenges

Table 14. Substance Abuse Therapeutics Market Restraints

Table 15. Global Substance Abuse Therapeutics Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Substance Abuse Therapeutics Revenue Share by Players (2019-2024)

Table 17. Global Top Substance Abuse Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Substance Abuse Therapeutics as of 2023)

Table 18. Global Substance Abuse Therapeutics Industry Ranking 2022 VS 2023 VS 2024

Table 19. Global 5 Largest Players Market Share by Substance Abuse Therapeutics Revenue (CR5 and HHI) & (2019-2024)

Table 20. Global Key Players of Substance Abuse Therapeutics, Headquarters and Area Served

Table 21. Global Key Players of Substance Abuse Therapeutics, Product and Application

Table 22. Global Key Players of Substance Abuse Therapeutics, Product and Application

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Substance Abuse Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Substance Abuse Therapeutics Revenue Market Share by Type (2019-2024)

Table 26. Global Substance Abuse Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Substance Abuse Therapeutics Revenue Market Share by Type (2025-2030)

Table 28. Global Substance Abuse Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Substance Abuse Therapeutics Revenue Share by Application (2019-2024)

Table 30. Global Substance Abuse Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Substance Abuse Therapeutics Revenue Share by Application (2025-2030)

Table 32. North America Substance Abuse Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 33. North America Substance Abuse Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 34. North America Substance Abuse Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 35. North America Substance Abuse Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 36. North America Substance Abuse Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. North America Substance Abuse Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 38. North America Substance Abuse Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 39. Europe Substance Abuse Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 40. Europe Substance Abuse Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 41. Europe Substance Abuse Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 42. Europe Substance Abuse Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 43. Europe Substance Abuse Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Europe Substance Abuse Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 45. Europe Substance Abuse Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 46. China Substance Abuse Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 47. China Substance Abuse Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 48. China Substance Abuse Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 49. China Substance Abuse Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 50. Asia Substance Abuse Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 51. Asia Substance Abuse Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 52. Asia Substance Abuse Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 53. Asia Substance Abuse Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 54. Asia Substance Abuse Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 55. Asia Substance Abuse Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 56. Asia Substance Abuse Therapeutics Market Size by Region (2025-2030) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Substance Abuse Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Substance Abuse Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Substance Abuse Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Substance Abuse Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Substance Abuse Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 62. Middle East, Africa, and Latin America Substance Abuse Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Substance Abuse Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 64. Indivior Company Details

Table 65. Indivior Business Overview

Table 66. Indivior Substance Abuse Therapeutics Product

Table 67. Indivior Revenue in Substance Abuse Therapeutics Business (2019-2024) & (US$ Million)

Table 68. Indivior Recent Developments

Table 69. Pfizer Company Details

Table 70. Pfizer Business Overview

Table 71. Pfizer Substance Abuse Therapeutics Product

Table 72. Pfizer Revenue in Substance Abuse Therapeutics Business (2019-2024) & (US$ Million)

Table 73. Pfizer Recent Developments

Table 74. Alkermes Company Details

Table 75. Alkermes Business Overview

Table 76. Alkermes Substance Abuse Therapeutics Product

Table 77. Alkermes Revenue in Substance Abuse Therapeutics Business (2019-2024) & (US$ Million)

Table 78. Alkermes Recent Developments

Table 79. Novartis Company Details

Table 80. Novartis Business Overview

Table 81. Novartis Substance Abuse Therapeutics Product

Table 82. Novartis Revenue in Substance Abuse Therapeutics Business (2019-2024) & (US$ Million)

Table 83. Novartis Recent Developments

Table 84. Mylan Company Details

Table 85. Mylan Business Overview

Table 86. Mylan Substance Abuse Therapeutics Product

Table 87. Mylan Revenue in Substance Abuse Therapeutics Business (2019-2024) & (US$ Million)

Table 88. Mylan Recent Developments

Table 89. Cipla Company Details

Table 90. Cipla Business Overview

Table 91. Cipla Substance Abuse Therapeutics Product

Table 92. Cipla Revenue in Substance Abuse Therapeutics Business (2019-2024) & (US$ Million)

Table 93. Cipla Recent Developments

Table 94. Glenmark Company Details

Table 95. Glenmark Business Overview

Table 96. Glenmark Substance Abuse Therapeutics Product

Table 97. Glenmark Revenue in Substance Abuse Therapeutics Business (2019-2024) & (US$ Million)

Table 98. Glenmark Recent Developments

Table 99. Dr. Reddy's Laboratories Company Details

Table 100. Dr. Reddy's Laboratories Business Overview

Table 101. Dr. Reddy's Laboratories Substance Abuse Therapeutics Product

Table 102. Dr. Reddy's Laboratories Revenue in Substance Abuse Therapeutics Business (2019-2024) & (US$ Million)

Table 103. Dr. Reddy's Laboratories Recent Developments

Table 104. Teva Pharmaceutical Company Details

Table 105. Teva Pharmaceutical Business Overview

Table 106. Teva Pharmaceutical Substance Abuse Therapeutics Product

Table 107. Teva Pharmaceutical Revenue in Substance Abuse Therapeutics Business (2019-2024) & (US$ Million)

Table 108. Teva Pharmaceutical Recent Developments

Table 109. Research Programs/Design for This Report

Table 110. Key Data Information from Secondary Sources

Table 111. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Substance Abuse Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Substance Abuse Therapeutics Market Share by Type: 2023 VS 2030

Figure 3. Opioid Addiction Features

Figure 4. Tobacco/Nicotine Addiction Features

Figure 5. Alcohol Dependence Features

Figure 6. Global Substance Abuse Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Substance Abuse Therapeutics Market Share by Application: 2023 VS 2030

Figure 8. Hospital & Clinics Case Studies

Figure 9. Residential (non-hospital) Case Studies

Figure 10. Substance Abuse Therapeutics Report Years Considered

Figure 11. Global Substance Abuse Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Substance Abuse Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Substance Abuse Therapeutics Market Share by Region: 2023 VS 2030

Figure 14. Global Substance Abuse Therapeutics Market Share by Players in 2023

Figure 15. Global Top Substance Abuse Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Substance Abuse Therapeutics as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Substance Abuse Therapeutics Revenue in 2023

Figure 17. North America Substance Abuse Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Substance Abuse Therapeutics Market Share by Type (2019-2030)

Figure 19. North America Substance Abuse Therapeutics Market Share by Application (2019-2030)

Figure 20. North America Substance Abuse Therapeutics Market Share by Country (2019-2030)

Figure 21. United States Substance Abuse Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Substance Abuse Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Substance Abuse Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 24. Europe Substance Abuse Therapeutics Market Share by Type (2019-2030)

Figure 25. Europe Substance Abuse Therapeutics Market Share by Application (2019-2030)

Figure 26. Europe Substance Abuse Therapeutics Market Share by Country (2019-2030)

Figure 27. Germany Substance Abuse Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Substance Abuse Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Substance Abuse Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Substance Abuse Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Substance Abuse Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Substance Abuse Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. China Substance Abuse Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 34. China Substance Abuse Therapeutics Market Share by Type (2019-2030)

Figure 35. China Substance Abuse Therapeutics Market Share by Application (2019-2030)

Figure 36. Asia Substance Abuse Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 37. Asia Substance Abuse Therapeutics Market Share by Type (2019-2030)

Figure 38. Asia Substance Abuse Therapeutics Market Share by Application (2019-2030)

Figure 39. Asia Substance Abuse Therapeutics Market Share by Region (2019-2030)

Figure 40. Japan Substance Abuse Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. South Korea Substance Abuse Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. China Taiwan Substance Abuse Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Southeast Asia Substance Abuse Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. India Substance Abuse Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Australia Substance Abuse Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East, Africa, and Latin America Substance Abuse Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Substance Abuse Therapeutics Market Share by Type (2019-2030)

Figure 48. Middle East, Africa, and Latin America Substance Abuse Therapeutics Market Share by Application (2019-2030)

Figure 49. Middle East, Africa, and Latin America Substance Abuse Therapeutics Market Share by Country (2019-2030)

Figure 50. Brazil Substance Abuse Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Mexico Substance Abuse Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Turkey Substance Abuse Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia Substance Abuse Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Israel Substance Abuse Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. GCC Countries Substance Abuse Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Indivior Revenue Growth Rate in Substance Abuse Therapeutics Business (2019-2024)

Figure 57. Pfizer Revenue Growth Rate in Substance Abuse Therapeutics Business (2019-2024)

Figure 58. Alkermes Revenue Growth Rate in Substance Abuse Therapeutics Business (2019-2024)

Figure 59. Novartis Revenue Growth Rate in Substance Abuse Therapeutics Business (2019-2024)

Figure 60. Mylan Revenue Growth Rate in Substance Abuse Therapeutics Business (2019-2024)

Figure 61. Cipla Revenue Growth Rate in Substance Abuse Therapeutics Business (2019-2024)

Figure 62. Glenmark Revenue Growth Rate in Substance Abuse Therapeutics Business (2019-2024)

Figure 63. Dr. Reddy's Laboratories Revenue Growth Rate in Substance Abuse Therapeutics Business (2019-2024)

Figure 64. Teva Pharmaceutical Revenue Growth Rate in Substance Abuse Therapeutics Business (2019-2024)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions